FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

Health & LifestyleNews
817

Listen to article (english)

Translate to Spanish or other 102 languages!

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65. Image for illustration purposes
On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65. Image for illustration purposes

Mega Doctor News

- Advertisement -

Medical News Today

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Addyi was previously approved in 2015 for the treatment of HSDD in premenopausal women. Premenopause or “before” menopause refers to the reproductive time in a cisgender woman’s life when they have regular menstrual cycles.

- Advertisement -

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/fda-approves-daily-pill-treat-low-libido-women-postmenopause-explainer?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-12-19&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Heart Association Highlights 2025’s Major Research Findings
Next article
From Patient to Hero: Isaac Garza Delivers 2,089 Smiles This Holiday Season

More Articles

McAllen Cancer Survivor Takes Her Fight for Patients to Washington

For breast cancer survivor Elvia Gibbs, traveling from McAllen to Washington, D.C., was about more than advocating for legislation. It was an opportunity to tell lawmakers firsthand that cancer research and access to clinical trials can mean more time, hope, and quality of life for patients.

Changing Careers, Changing Lives: TSC Student Receives Prestigious Grant

Texas Southmost College student Eleazar Hernandez is blazing a trail as a standout in the college’s Respiratory Care Science program, earning recognition for his work at both the regional and statewide levels for his academic and research achievements. 

What Your Sibling Rank Means for Your Long-Term Health

Anyone who has a brother or sister knows that siblings raised under the same roof can show stark dissimilarities when it comes to everything from favorite colors to food allergies.

Susie Wiles Announces She Is Cancer-Free Following Breast Cancer Treatment

White House Chief of Staff Susie Wiles announced Wednesday that she is cancer-free following months of treatment for early-stage breast cancer, sharing the news after receiving clear pathology results from the Mayo Clinic.
- Advertisement -